Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by biorunon Feb 10, 2022 9:29am
156 Views
Post# 34415996

Animal Health - TFC039

Animal Health - TFC039

Jimmy,

Further to my earlier remark on the Feb presentation, I am somewhat focused to understand what this bullet means. They use "advanced discussion" so that means something to me, ONLY in particular now that Linda Pullan is in the equation:

"In advanced discussions with three major interested parties from the animal health sector"

At first glance, I assumed that one of the three partners would be Wanbang, however I have since confirmed that they are not "one of the three major interested parties" noted. Perhaps they are a partner to formulate product as they did actually produce sglt2 pills for the human trials and we do know from some other patents that the Sirona tablets were supplied to Boehringer as well to support the testing required to firm up their patents (or have very very high probability in my opinion)

Elanco is very likely one of them as they were noted in the financials, Boehringer did a cat study a year or more ago specifically testing a new diabetic formula in a trial format, and they are someway connected to the patent activity noted above, and so that leaves me wondering who is number 3.

If three players are all collaborating here to get a deal signed up, then that says to me, from a business perspective, that all three are comfortable using the same product and branding it/globally marketing it under their own banners (maybe). Enter Wanbang: these guys are good at one thing (other than jerkin us around on human trials which we are not disputing), and that is manufacturing generic drugs at very low unit cost.

So my mind is boggled here with the prospect on Animal Health. Three global players in Animal Health - is it possible that IF this agreement is formed, then it would entirely dwarf the top 10 scenario?  I don't know. But three big ones are better than 1.

But with Sirona and its history I am fully tempered with the fact that nothing is real until it is in writing in the form of announcement, so nobody should make a buy decision on that. My musings are just that.






 

<< Previous
Bullboard Posts
Next >>